-DOCSTART- -X- O
Traditional -X- _ O
microbiological -X- _ O
methods -X- _ O
for -X- _ O
detection -X- _ O
of -X- _ O
respiratory -X- _ O
tract -X- _ O
pathogens -X- _ O
can -X- _ O
be -X- _ O
slow -X- _ O
, -X- _ O
are -X- _ O
often -X- _ O
not -X- _ O
sensitive -X- _ O
, -X- _ O
may -X- _ O
not -X- _ O
distinguish -X- _ O
infection -X- _ O
from -X- _ O
colonization -X- _ O
, -X- _ O
and -X- _ O
are -X- _ O
influenced -X- _ O
by -X- _ O
previous -X- _ O
antibiotic -X- _ O
therapy. -X- _ O
Molecular -X- _ B-Intervention
diagnostic -X- _ I-Intervention
tests -X- _ I-Intervention
for -X- _ I-Intervention
common -X- _ I-Intervention
and -X- _ I-Intervention
atypical -X- _ I-Intervention
causative -X- _ I-Intervention
pathogens -X- _ I-Intervention
of -X- _ O
community-acquired -X- _ B-Patient
pneumonia -X- _ I-Patient
have -X- _ O
the -X- _ O
potential -X- _ O
to -X- _ O
dramatically -X- _ B-Outcome
increase -X- _ I-Outcome
the -X- _ I-Outcome
diagnostic -X- _ I-Outcome
yield -X- _ I-Outcome
and -X- _ I-Outcome
decrease -X- _ I-Outcome
the -X- _ I-Outcome
time -X- _ I-Outcome
required -X- _ I-Outcome
to -X- _ I-Outcome
render -X- _ I-Outcome
results. -X- _ I-Outcome
Unfortunately -X- _ O
, -X- _ O
these -X- _ O
tests -X- _ O
often -X- _ O
lack -X- _ B-Outcome
standardization -X- _ I-Outcome
and -X- _ I-Outcome
are -X- _ I-Outcome
not -X- _ I-Outcome
widely -X- _ I-Outcome
available. -X- _ I-Outcome
Consideration -X- _ O
should -X- _ O
be -X- _ O
given -X- _ O
to -X- _ O
the -X- _ O
development -X- _ O
and -X- _ O
evaluation -X- _ O
of -X- _ O
companion -X- _ B-Intervention
molecular -X- _ I-Intervention
diagnostic -X- _ I-Intervention
tests -X- _ I-Intervention
for -X- _ I-Intervention
detection -X- _ I-Intervention
of -X- _ I-Intervention
respiratory -X- _ I-Intervention
pathogens -X- _ I-Intervention
in -X- _ O
future -X- _ O
clinical -X- _ O
trials -X- _ O
of -X- _ O
antimicrobials -X- _ O
intended -X- _ O
to -X- _ O
treat -X- _ O
community-acquired -X- _ B-Patient
pneumonia -X- _ I-Patient
. -X- _ O

